About AgPlus Diagnostics
AgPlus Diagnostics is a company based in Sharnbrook (United Kingdom) founded in 2011. The company has 8 employees as of December 31, 2021. AgPlus Diagnostics offers products and services including Agilis Reader and AgPlus Assays. AgPlus Diagnostics operates in a competitive market with competitors including Gemelli Biotech, GNA Biosolutions, NanoVation-GS, Tethis and Entopsis, among others.
- Headquarter Sharnbrook, United Kingdom
- Employees 8 as on 31 Dec, 2021
-
Sectors
TechnologyHealthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Agplus Diagnostics Ltd
- Date of Incorporation 19 Aug, 2009
- Jurisdiction LONDON
-
Annual Revenue
$597.12 K (USD)-23as on Dec 31, 2020
-
Net Profit
-$699.36 K (USD)-7as on Dec 31, 2020
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
8
as on Dec 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of AgPlus Diagnostics
AgPlus Diagnostics offers a comprehensive portfolio of products and services, including Agilis Reader and AgPlus Assays.
Portable reader for quantitative blood testing in healthcare.
Multiplex tests for detecting diseases in clinical settings.
People of AgPlus Diagnostics
Unlock access to complete
Unlock access to complete
Funding Insights of AgPlus Diagnostics
Investors in AgPlus Diagnostics
AgPlus Diagnostics has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include UKI2S.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage innovations are funded by UKI2S across key sectors.
|
Locked | Locked | Locked |
Investor details for AgPlus Diagnostics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by AgPlus Diagnostics
Investment portfolio details for AgPlus Diagnostics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - AgPlus Diagnostics
Detailed financials for AgPlus Diagnostics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Agplus Diagnostics Comparisons
Peer comparison for AgPlus Diagnostics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of AgPlus Diagnostics
AgPlus Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Gemelli Biotech, GNA Biosolutions, NanoVation-GS, Tethis and Entopsis, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Diagnostics and therapeutics for the human microbiome are provided.
|
|
| Locked | Locked | Locked |
Instruments and assays for molecular pathogen detection are developed.
|
|
| Locked | Locked | Locked |
Nanomaterial-based sensors for respiratory monitoring devices are developed.
|
|
| Locked | Locked | Locked |
Automated solutions for liquid biopsy processing are provided.
|
|
| Locked | Locked | Locked |
Diagnostic devices for health monitoring are developed using specialized slides.
|
|
| Locked | Locked | Locked |
Developer of a diagnostic device that uses quantum dot nanoparticles to provide real-time patient testing
|
Detailed competitors of AgPlus Diagnostics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Agplus Diagnostics
Complete news archive for AgPlus Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about AgPlus Diagnostics
AgPlus Diagnostics was founded in 2011 and raised its 1st funding round 5 years after it was founded.
AgPlus Diagnostics is headquartered in Sharnbrook, United Kingdom. It is registered at Sharnbrook, England, United Kingdom.
As of Dec 31, 2021, the latest employee count at AgPlus Diagnostics is 8.
Annual revenue of AgPlus Diagnostics is $597.12K as on Dec 31, 2020.
AgPlus Diagnostics was founded in 2011 in Sharnbrook, United Kingdom, as a technology development company. Portable platforms and test cartridges are created for applications in human diagnostics, veterinary diagnostics, sports, military, and environmental sectors. Electrochemistry and nanotechnology form the basis of the handheld technology. A partnership with AstraZeneca was announced in 2016 for prototyping a diagnostic assay to support respiratory disease treatment.
AgPlus Diagnostics's top competitors include Tethis, GNA Biosolutions and Gemelli Biotech.
AgPlus Diagnostics offers Agilis Reader and AgPlus Assays.
AgPlus Diagnostics has 1 investor. Key investors include UKI2S.